We are a healthcare market research and behavioural science agency determined to do things differently. Hummingbird Insight was born out of the bravery and desire for the freedom to challenge, create, and disrupt – necessary catalysts to truly great strategies that question assumptions and push boundaries within the rules. Our researchers and psychologists are passionate about delivering insights-enabled activation, not merely reporting on the status-quo. What this means for you? Sleek, yet profoundly simple insights and solutions to take your program or your brand to its fullest potential.
Nayana is a senior researcher dedicated to social and health issues. Over the years, she has successfully helped her clients launch their program or product optimally, or regain performance they had lost.
Nayana provides government agencies and healthcare brand teams with a complete picture of the challenges they need to tackle – from defining the issue at hand to providing its solution.
Nayana wanted to re-shape the face of social and healthcare research by bringing innovations she learned from other industries. It is with that aspiration at heart that she founded HUMMINGBIRD INSIGHT.
Senior Research Director
Lisa is a dualist researcher. In her view, qual and quant are not separate streams and a keen grasp of both is essential for her work with brand teams.
Her role is to deliver a cohesive story to her clients, to fill the knowledge gap, and provide strategic guidance:
1) Knowledge – use a breadth of methodology and therapy area knowledge to design solutions that best fit the social or commercial needs
2) Clarity of thought - Lisa strives to provide clear stories, clear answers, and clear and realistic strategic recommendations
3) Communication - report writing is something of an art form to Lisa - what do the audience need to know, and how to best tell the story to drive home the key message?
Debby is a market research dualist with a background in medical biotechnology and marketing. She values working in the healthcare industry as it allows her to make a difference in people’s lives.
Throughout her career, Debby has had the opportunity to embrace a variety of research techniques, including Electroencephalography (EEG) and eye tracking devices to dig deep into cognitive processes.
As a driven and outcome-focused individual, she enjoys analysing both qualitative and quantitative data and converting insights into actionable business decisions.
Richard has over 15 years’ experience in market research in Australia and the UK, working on projects for leading companies internationally and within Australia. Highly experienced in both quantitative and qualitative research, he works with both traditional and advanced quantitative methodologies including segmentation, choice modelling and forecasting. He is passionate about the projects he works on and enjoys working with clients to find meaningful insight and provide practical answers to their business issues.
Johny is a dualist qualitative and quantitative researcher, with over 5 years’ experience within the healthcare industry. He joined Hummingbird in 2019 as a Research Manager, bringing over his consultative skills developed previously by working with major pharmaceutical and consumer health brands teams. He is an engaged researcher who understands the commercial needs of his clients and enjoys seeing them implement the insights he uncovered. At Hummingbird, he combines his strong foundation in research with his keen interest in pioneering methodologies including incorporating Behavioural Science to deliver targeted solutions. Graduating with First Class Honours in Medicinal Chemistry, the pharmaceutical space has always been close to his heart.
Research & Behavioural Science Associate
Giulia is a bright junior behavioural neuroscientist with a keen interest in research related to health behaviour change. With strong academic credentials, she holds a Bachelor of Science (Neuroscience with Psychology) and has recently completed her Master of Psychology majoring in Behavioural Neuroscience from The University of British Colombia. Her master’s degree project aimed to understand the neurocircuits of avoidance in decision making. As such, she trained rats, operated on rats, collected and analysed data, and reported on the achieved behaviour change. Giulia is excited to use her academic learnings to service and make a difference to the pharmaceutical industry.
Emmett is a market research fieldwork specialist who has been working in the Healthcare space for over 15 years. During this time, Emmett has developed a deep understanding of the Australian industry of healthcare professionals from both a qualitative & quantitative perspective. He has been involved in the development of one of Australian largest market research panels of healthcare professionals and is passionate about working with Hummingbird’s team of researchers to deliver clear & concise results across all our projects.
Alena is a psychologist and dualist researcher with over 15 years’ experience in commercial research and consulting across a breadth of therapy areas and health populations.
Her specialism lies in diagnosing human behaviour and partnering with clients to translate science-based insights into actionable outcomes that become tools to effectively move business metrics; she takes pride in her ability to input strategy that is easily understood and immediately useful.
Proof of her success comes with clients being showcased globally as best-practice brand execution.
Alena has deep, hands-on experience leading successful programs across the full range of brand lifecycle, from pre-launch exploration to market share defence beyond loss of exclusivity, with particular strength in launch strategy and customer segmentation. She is passionate about optimising the balance between scientific rigour and practical simplicity, choosing the right approach for each unique brief, and her combination of qualitative and advanced quantitative skills make her an expert in discerning implications from the available (often small) target market.
Alex is an accomplished pharma marketer with more than 8 years of international experience in Germany and Australia. Graduating in the UK from the University of Westminster with a First Class Honours in Business Studies, Alex combines her strong marketing background with her devotion for contemporary health care solutions and has worked on innovative strategies across general practise, hospital as well as specialty and aged care.
At Hummingbird, Alex is pairing her profound passion for insights and behavioural science with her strategic marketing skills to provide novel, insights-enabled solutions to the health care industry. Alex’s key priority is to ensure a problem is illuminated from every possible angle in order to tailor solutions that are leading-edge and customer-centric yet practical and actionable.
Kathryn is a bright junior qualitative and quantitative market research dualist. She has 18 months market research experience; inclusive of both agency and client-side capacities.
Kathryn began her career working in social and government research and has recently transitioned to healthcare and pharmaceutical research because she is passionate about making a meaningful change in peoples’ lives.
Throughout her time in social and government research, Kathryn worked across a multitude of research projects utilising various research methodologies. Kathryn is passionate about research and takes great pride in her work; striving to deliver meaningful and actionable insights to all her clients.
2018-02-19 | Behavioural Science
Dame Carol Black's Review of the health of Britain's working age population
2018-02-19 | Behavioural Science
Report on the trial undertaken by the Behavioural Insights Unit, Allianz and the Department of Education
2017-11-23 | Behavioural Science
How behavioural science can improve health literacy and healthcare decisions.
2017-11-23 | Behavioural Science
There is a growing realisation in pharmaceutical marketing that physicians are not the logical, data-driven decision makers classical economists want us to think they are. Efficacy and clinical data become table stakes in many cases and are only casual factors in the choice of medications.